Company: SCLXW
Filing Date: 2025-01-17
Form Type: 10-Q
Source: 0000950170-25-006755
Chunk: 88

Company: Scilex Holding Co
Filing Date: 2025-01-17
Form: 10-Q
Item: Item 1
Chunk 88
---
 Scilex Holding Company 2023 Inducement Plan (the “Inducement Plan”). The Inducement Plan provides for the grant of equity-based awards in the form of non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, and other awards solely to prospective employees of the Company or an affiliate of the Company provided that certain criteria are met. The initial maximum number of shares available for grant under the Inducement Plan is 1,400,000 shares of Common Stock (subject to adjustment for recapitalizations, stock splits, reorganizations and similar transactions). No awards were granted under the Inducement Plan during the nine months ended September 30, 2024. As of September 30, 2024, options to purchase 34,361,475 shares of Common Stock were outstanding under all equity incentive plans. The following table summarizes stock option activity during the nine months ended September 30, 2024 (in thousands, except for per share amounts and contractual life): 

        Options

        Weighted-Average Exercise Price

        Weighted-Average Remaining Contractual Life,  in years

        Aggregate Intrinsic Value

        Outstanding as of December 31, 2023
         
        33,124

        $
        4.38

        7.5

        $
        7,459

        Granted
         
        1,867

        $
        1.04

        Exercised
         
        (154
        )
         
        $
        1.48

        Forfeited/cancelled
         
        (476
        )
         
        $
        6.85

        Outstanding as of September 30, 2024
         
        34,361

        $
        4.17

        6.7

        $
        224

        Exercisable as of September 30, 2024
         
        22,652

        $
        3.33

        5.8

        $
        200

       Intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the Common Stock for the options that had exercise prices that were lower than the per share fair value of the Common Stock as of the measurement date of the intrinsic value. The weighted-average grant date fair value per share of stock options granted during the nine months ended September 30,